2050906-40-4

2050906-40-4 structure

Name:
Chemical Name:
CAS Number: 2050906-40-4
Molecular Formula: C₂₇H₃₂N₈O₃
Molecular Weight: 516.6
Catalog: Signaling Pathways JAK/STAT Signaling EGFR
Create Date: 2020-06-01 16:22:35
Modify Date: 2026-08-03 16:53:59
BEBT-109 is a potent pan-mutant-selective EGFR inhibitor. BEBT-109 has improved pharmacokinetic properties. BEBT-109 can be used for multiple mutant-EGFR-driven non-small cell lung cancer (NSCLC) research[1].

No information of Name

Description	BEBT-109 is a potent pan-mutant-selective EGFR inhibitor. BEBT-109 has improved pharmacokinetic properties. BEBT-109 can be used for multiple mutant-EGFR-driven non-small cell lung cancer (NSCLC) research[1].
Related Catalog	Research Areas >> Cancer Signaling Pathways >> JAK/STAT Signaling >> EGFR Signaling Pathways >> Protein Tyrosine Kinase/RTK >> EGFR
References	[1]. Fan F, et al BEBT-109, a pan-mutant-selective EGFR inhibitor with potent antitumor activity in EGFR-mutant non-small cell lung cancer. Transl Oncol. 2021 Feb;14(2):100961.